Quantcast

Latest Daptomycin Stories

2014-08-12 23:10:30

On August 9, Cubist Pharmaceuticals, Inc. announced the recall of certain lots of Cubicin (daptomycin for injection) 500 mg due to the presence of particulate matter. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) August 12, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Cubicin (daptomycin for...

2014-04-25 23:07:58

As the FDA announced on April 18, one lot of Cubicin (daptomycin for injection), by Cubist Pharmaceuticals, is recalled due to the presence of particular matter. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) April 25, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for drugs. On April...

Antibiotic Resistance Threats In The US: CDC
2013-09-17 05:04:01

redOrbit Staff & Wire Reports - Your Universe Online Antibiotic-resistant “superbugs” kill approximately 23,000 Americans each year, the US Centers of Disease Control and Prevention (CDC) revealed on Monday. In addition, federal health officials also reported that at least two million people fall ill due to these bacterial infections, reports Mike Stobbe and Lindsey Tanner of the Associated Press (AP). This marks the first time that the CDC has released statistics addressing the...

2011-11-11 18:25:13

Infectious diseases specialists from Austin Health are working closely with Microbiologists from the University of Melbourne to understand how Staph is becoming resistant to all antibiotic therapies. The treatment of serious infections caused by Staphylococcus aureus (Golden Staph) is complicated by the development of antibiotic resistance. Seriously ill patients, vulnerable to infections can be at additional risk if antimicrobial agents become less effective in fighting infections....

2011-09-08 20:04:51

An analysis of the genome of a superbug has yielded crucial, novel information that could aid efforts to counteract the bacterium´s resistance to an antibiotic of last resort. The results of the research led by scientists from The University of Texas Health Science Center at Houston (UTHealth) are published in the Sept. 8 issue of the New England Journal of Medicine. Superbugs are bacteria that are resistant to multiple antibiotics and represent one of the most challenging health...

2011-07-14 12:46:04

Mass. Eye and Ear, Harvard Medical School investigators share finding in July 2011 issue of Antimicrobial Agents and Chemotherapy Hospitals struggle to prevent the infections that complicate treatment for cancer, joint replacement, heart surgery and other conditions. Hospital-acquired infections are often resistant to multiple antibiotics, leading to approximately 100,000 deaths and more than $30 billion in additional health care costs yearly. New drugs are being developed to combat these...

2011-06-27 05:30:00

DALLAS, June 27, 2011 /PRNewswire/ -- ReportsnReports announces it will carry 'Daptomycin - Comprehensive patent search'Report in its store Browse the complete 'Daptomycin - Comprehensive patent search [http://www.reportsnreports.com/reports/90113-daptomycin-comprehensive-patent-search.html ] 'Report now! Search 75000+ Market Research Reports [http://www.reportsnreports.com ] Browse All Pharmaceutical Market Research Reports...

2011-06-16 08:00:00

LEXINGTON, Mass., June 16, 2011 /PRNewswire-USNewswire/ -- Cubist Pharmaceuticals, Inc. today praised Rep. Phil Gingrey, R-Ga., and co-sponsors for introducing the Generating Antibiotic Incentives Now (GAIN) Bill of 2011. This critical piece of legislation was crafted to help restore a robust antibiotic development pipeline to address the growing public health threat due to emerging multi-drug-resistant (MDR) bacteria. The bi-partisan legislation calls for the enactment of specific...

2011-04-06 06:00:00

SAN DIEGO, April 6, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) and Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the signing of an exclusive two-year co-promotion agreement to market DIFICID(TM) (fidaxomicin), in the United States. DIFICID is a novel antibiotic currently being reviewed for market approval by the FDA for the treatment of Clostridium difficile infection (CDI), which is also known as Clostridium difficile-associated diarrhea (CDAD)....


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related